2017 American Transplant Congress Archives - Page 2 of 181

2:30pm-2:42pm: Emergency Department Utilization Among Kidney Transplant Recipients in the United States.

B. Lovasik, R. Zhang, J. Schrager, S. Pastan, A. Adams, R. Patzer.

Concurrent Session: Kidney Clinical Psychosocial • E354b

2:30pm-2:42pm: Gene Expression Profiling for the Identification and Classification of Antibody-Mediated Heart Rejection.

A. Loupy,¹ J. Duong Van-Huyen,¹ L. Hidalgo,² J. Reeve,² M. Racapé,¹ O. Aubert,¹ J. Venner,² D. Viglietti,¹ P. Bruneval,¹ C. Lefaucheur,¹ P. Halloran.²

Concurrent Session: Heart Transplantation: Antibodies and Outcomes • E271b

2:30pm-2:42pm: Induction of Sensitization and Resistance to Transplant Tolerance by Allogeneic Pregnancy.

A. Suah,¹ J. Young,¹ S. Hsu-Wei Khiew,¹ Q. Wang,¹ D. Yin,¹ M.-L. Alegre,² A. Chong.¹

Concurrent Session: Basic Transplant Tolerance I • E350

2:30pm-2:42pm: Ischemia-Reperfusion Injury-Induced Innate Immune Signaling in Human Orthotopic Liver Transplantation.

R. Sosa,¹ A. Zarrinpar,² M. Rossetti,¹ C. Lassman,¹ B. Naini,¹ N. Datta,² R. Busuttil,² D. Gjertson,¹ J. Kupiec-Weglinski,^1,2 E. Reed.¹

Concurrent Session: Organ Perfusion Strategies • E353C

2:30pm-2:42pm: Liver Retransplantation: The Largest Post MELD Single Center Experience.

F. Kaldas, I. Korayem, V. Agopian, T. Russell, S. Ebaid, A. Zarrinpar, H. Yersiz, D. Farmer, R. Busuttil.

Concurrent Session: Liver Retransplantation and Other Complications • E353B

2:30pm-2:42pm: Saftey & Long Term Outcomes of Tocilizumab (Anti-IL6R, TCZ) Therapy in Treatment of Chronic Antibody Mediated Rejection (CABMR) & Transplant Glomerulopathy (TG) in Highly-HLA Sensitized (HS) Patients (PTs).

J. Choi,¹ O. Aubert,² A. Vo,¹ A. Loupy,² M. Haas,³ S. Louie,¹ A. Kang,¹ A. Peng,¹ R. Najjar,¹ E. Huang,¹ M. Toyota,⁵ X. Zhang,⁴ S. Jordan.¹

Concurrent Session: Treatment of Antibody Mediated Rejection in Kidney Transplant Recipients • E354a

2:30pm-2:42pm: Transplant Economics Post Implementation of the Affordable Care Act and the Budget Control Act Sequestration Adjustment on Medicare Reimbursement.

E. Zavala,¹ J. Rogers,² R. Howey,³ S. Karp.¹

Concurrent Session: Transplant Regulation and Management: Allocation, Access and Other Transplant Management Topics • E451b

2:42pm-2:54pm: CD4 T Cell Migration Across Lymphatic Endothelium Is Enhanced by Sphingosine 1-Phosphate (S1P) and Differentially Regulated by S1P Receptors (S1PR).

Y. Xiong,¹ C. Brinkman,¹ K. Hippen,² B. Blazar,² J. Bromberg.¹

Concurrent Session: Mechanisms of Allograft Rejection • E352

2:42pm-2:54pm: Composite Prognostic Score Improves Clinical Benefit in Kidney Recipients Receiving Standard of Care Therapy for Antibody-Mediated Rejection.

D. Viglietti, A. Loupy, O. Aubert, E. Pillebout, C. Legendre, D. Glotz, C. Lefaucheur.

Concurrent Session: Treatment of Antibody Mediated Rejection in Kidney Transplant Recipients • E354a

2:42pm-2:54pm: Contemporary Outcomes and Risk Factors of Acute Graft-versus-Host Disease After Liver Transplant.

J. Markus, A. Bukannan, B. Kashat, R. Salgia.

Concurrent Session: Liver Retransplantation and Other Complications • E353B